CIK 0001434316
- Non-accelerated filer
- Smaller reporting company
FATE THERAPEUTICS INC
Sign in to watch- Ticker
- FATE
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 651311552
- Phone
- +1 858-875-1803
- Business address
- 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,525
- in 1 filing
Net −$13,525. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-04 | TAHL CINDY | Sale | −38,800 | $2.46 | $95K | 589,355 |
| 2026-05-20 | TAHL CINDY | Sale | −25,590 | $1.88 | $48K | 628,155 |
| 2026-05-06 | TAHL CINDY | Exercise or conversion | +122,220 | $1.32 | $161K | 609,301 |
| 2026-05-06 | TAHL CINDY | Exercise or conversion | +44,444 | $1.05 | $47K | 653,745 |
| 2026-05-06 | TAHL CINDY | Exercise or conversion · Stock Option (Right to Buy) | −122,220 | 152,780 | ||
| 2026-05-06 | TAHL CINDY | Exercise or conversion · Stock Option (Right to Buy) | −44,444 | 355,556 | ||
| 2026-01-15 | TAHL CINDY | Grant or award | +100,000 | 487,081 | ||
| 2026-01-15 | TAHL CINDY | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2026-01-09 | TAHL CINDY | Sale | −10,589 | $1.06 | $11K | 387,081 |
| 2025-08-04 | TAHL CINDY | Sale | −9,037 | $1.06 | $10K | 397,670 |
| 2025-01-15 | TAHL CINDY | Grant or award | +70,000 | 406,707 | ||
| 2025-01-15 | TAHL CINDY | Grant or award · Stock Option (Right to Buy) | +275,000 | 275,000 | ||
| 2025-01-10 | TAHL CINDY | Sale | −5,654 | $1.55 | $9K | 336,707 |
| 2024-07-29 | TAHL CINDY General Counsel and Secretary | Grant or award | +200,000 | 342,361 | ||
| 2024-02-01 | TAHL CINDY General Counsel and Secretary | Grant or award · Stock Option (Right to Buy) | +425,000 | 425,000 | ||
| 2024-01-09 | TAHL CINDY General Counsel and Secretary | Sale | −10,874 | $4.37 | $48K | 142,361 |
| 2023-11-09 | TAHL CINDY General Counsel and Secretary | Sale 10b5-1 | −24,363 | $2.40 | $58K | 153,235 |
| 2023-02-06 | TAHL CINDY General Counsel and Secretary | Grant or award · Stock Option (Right to Buy) | +425,000 | 425,000 | ||
| 2023-01-10 | TAHL CINDY General Counsel and Secretary | Sale | −11,553 | $5.24 | $61K | 177,598 |
| 2022-06-01 | TAHL CINDY General Counsel and Secretary | Exercise or conversion | +25,000 | $6.55 | $164K | 214,151 |
Page 1 of 7 · 134 trades